Key facts
- Devoted’s last known valuation is $13.0B (Aug 2024).
- It has raised $2.7B; the latest was Later Stage VC ($366.0M) in Jan 2026.
- Notable investors include Andreessen Horowitz, General Catalyst, Impact Assets, GV, Capital Factory — 56 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 56 names
- ·Watchlist + deal alerts for Devoted
- ·The full record, as it builds
Funding rounds
No funding rounds for Devoted are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Devoted
Provider of healthcare planning services intended to improve the quality of patient care by offering personalized medical plans. The company's healthcare plans feature personal guides, contracts, and Medicare Advantage plans that help to work closely with physicians to avoid unnecessary medical procedures, enabling patients to access healthcare through a network of doctors and tech-enabled platforms.
- Sector
- Healthcare
- HQ
- Waltham, MA, United States
- Founded
- 2017
- Employees
- 2,023
- Website
- devoted.com/
- Ownership
- Privately Held (backing)
Devoted doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Devoted shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Devoted in its N-PORT filings yet. We sweep new filings monthly.